“…Consistent results were obtained in a recent study which showed that N -acetylsepaconitine (40) could significantly prolong the ventricular premature (VP) action in aconitine-induced arrhythmia mice, with an effect better than that of lappaconitine, while their inhibition of ventricular tachycardia (VT) and ventricular flutter (VFL) was similar. 75 From the data available, the presence of amino or anthranoyl groups at the C-18 position is required for the antiarrhythmic activity of C 18 -DAs, and their antiarrhythmic action is closely related to the methoxyl groups at C-1, C-14, and C-16, along with the hydroxyl group at C-8. Therefore, more efficient antiarrhythmic agents using available natural C 18 -DAs as lead compounds could be designed based on SAR analysis.…”